Acquiring Company
Zimmer
Acquired Company
Pacira CryoTech
WarsawCaliforniaManufacturingInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMedicalMedical Devicemedical devicesBiotechnologyHealth CareMedical DeviceDescription
On June 28, 2026, Pacira Biosciences, Inc. entered into a Stock and Asset Purchase Agreement with Zimmer, Inc. to divest its wholly owned subsidiary, Pacira CryoTech, Inc. The agreement entails the sale of all outstanding capital stock of the subsidiary along with certain assets and liabilities related to its handheld cryoanalgesia devices. The total transaction value is up to $140 million, with an upfront payment of $70 million.
Fundz sees it the moment Zimmer makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Pacira CryoTech?
Pacira CryoTech was acquired by Zimmer, based in Warsaw. The deal was reported on June 30, 2026. Zimmer, Inc. is a subsidiary of Zimmer Biomet Holdings, Inc., specializing in orthopedic reconstructive products and related services. Zimmer is publicly traded (ZBH) and operates in Manufacturing.
When did Zimmer acquire Pacira CryoTech?
Zimmer's acquisition of Pacira CryoTech was reported on June 30, 2026. On June 28, 2026, Pacira Biosciences, Inc. entered into a Stock and Asset Purchase Agreement with Zimmer, Inc. to divest its wholly owned subsidiary, Pacira CryoTech, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pacira CryoTech do?
Pacira CryoTech, Inc. is a wholly owned subsidiary of Pacira Biosciences, Inc. that specializes in handheld cryoanalgesia devices and related products. The company is known for its flagship device, iovera®°, which provides non-opioid pain management solutions. It is privately held, operating in Biotechnology, and is based in California.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.